Cancer Drugs, Genetic Variation and the Glutathione-S-Transferase Gene Family
- 1 January 2003
- journal article
- review article
- Published by Springer Science and Business Media LLC in American Journal of PharmacoGenomics
- Vol. 3 (3), 157-172
- https://doi.org/10.2165/00129785-200303030-00002
Abstract
The glutathione-S-transferase (GST) super family comprises multiple isozymes (Alpha, Mu, Pi, Omega, Theta, and Zeta) with compelling evidence of functional polymorphic variation. Over the last two decades, a significant body of data has accumulated linking aberrant expression of GST isozymes with the development and expression of resistance to cancer drugs. Clinical correlation studies show that genetic differences within the human GST isozymes may play a role in cancer susceptibility and treatment. The initial confusion was presented by the fact that not all drugs used to select for resistance were substrates for thioether bond catalysis by GSTs. However, recent evidence that certain GST isozymes possess the capacity to regulate mitogen activated protein kinases presents an alternative explanation. This dual functionality has contributed to the recent efforts to target GSTs with novel small molecule therapeutics. While the ultimate success of these attempts remains to be shown, at least one drug is in late-stage clinical testing. In addition, the concept of designing new drugs that might interfere with protein:protein interactions between GSTs and regulatory kinases provides a novel approach to identify new targets in the search for cancer therapeutics.Keywords
This publication has 41 references indexed in Scilit:
- Activation of the p38 Signaling Pathway by Heat Shock Involves the Dissociation of Glutathione S-Transferase Mu from Ask1Online Journal of Public Health Informatics, 2002
- Glutathione S-transferase P1–1 (GSTP1–1) Inhibits c-Jun N-terminal Kinase (JNK1) Signaling through Interaction with the C TerminusOnline Journal of Public Health Informatics, 2001
- Regulation of JNK signaling by GSTpThe EMBO Journal, 1999
- Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1The EMBO Journal, 1998
- Structure, Catalytic Mechanism, and Evolution of the Glutathione TransferasesChemical Research in Toxicology, 1997
- The Glut athione S-Transferase Supergene Family: Regulation of GST and the Contribution of the lsoenzymes to Cancer Chemoprotection and Drug Resistance Part ICritical Reviews in Biochemistry and Molecular Biology, 1995
- The developmental expression of alpha-, mu- and pi-class glutathione S-transferases in human liverBiochimica et Biophysica Acta (BBA) - General Subjects, 1989
- Glutathione Transferases—Structure and Catalytic ActivitCritical Reviews in Biochemistry, 1988
- The basic glutathione S-transferases from human livers are products of separate genesBiochemical and Biophysical Research Communications, 1987
- Ligandin: a Hepatic Protein which Binds Steroids, Bilirubin, Carcinogens and a Number of Exogenous Organic AnionsNature, 1971